nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Lupus-like syndrome—Dapsone—leprosy	0.0854	0.0854	CcSEcCtD
Quinidine barbiturate—Mental state abnormal—Thalidomide—leprosy	0.0761	0.0761	CcSEcCtD
Quinidine barbiturate—Hangover—Thalidomide—leprosy	0.0437	0.0437	CcSEcCtD
Quinidine barbiturate—Anaemia megaloblastic—Thalidomide—leprosy	0.0437	0.0437	CcSEcCtD
Quinidine barbiturate—Myasthenia—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Quinidine barbiturate—Nystagmus—Thalidomide—leprosy	0.0144	0.0144	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Dapsone—leprosy	0.0129	0.0129	CcSEcCtD
Quinidine barbiturate—Petechiae—Thalidomide—leprosy	0.0125	0.0125	CcSEcCtD
Quinidine barbiturate—Apnoea—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Quinidine barbiturate—Vasodilation procedure—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Quinidine barbiturate—Vasodilation—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Dapsone—leprosy	0.0115	0.0115	CcSEcCtD
Quinidine barbiturate—Bone disorder—Thalidomide—leprosy	0.0114	0.0114	CcSEcCtD
Quinidine barbiturate—Thinking abnormal—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Quinidine barbiturate—Hypocalcaemia—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Quinidine barbiturate—Oliguria—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Quinidine barbiturate—Hearing impaired—Thalidomide—leprosy	0.0108	0.0108	CcSEcCtD
Quinidine barbiturate—Atrioventricular block—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Quinidine barbiturate—Depressed level of consciousness—Thalidomide—leprosy	0.00995	0.00995	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Thalidomide—leprosy	0.00967	0.00967	CcSEcCtD
Quinidine barbiturate—Tinnitus—Dapsone—leprosy	0.00942	0.00942	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Thalidomide—leprosy	0.00941	0.00941	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Thalidomide—leprosy	0.00917	0.00917	CcSEcCtD
Quinidine barbiturate—Hyperkinesia—Thalidomide—leprosy	0.00898	0.00898	CcSEcCtD
Quinidine barbiturate—Mental disability—Thalidomide—leprosy	0.00894	0.00894	CcSEcCtD
Quinidine barbiturate—Erythema—Dapsone—leprosy	0.0088	0.0088	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Thalidomide—leprosy	0.00852	0.00852	CcSEcCtD
Quinidine barbiturate—Deafness—Thalidomide—leprosy	0.00836	0.00836	CcSEcCtD
Quinidine barbiturate—Eczema—Thalidomide—leprosy	0.00832	0.00832	CcSEcCtD
Quinidine barbiturate—Vision blurred—Dapsone—leprosy	0.00829	0.00829	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Thalidomide—leprosy	0.0081	0.0081	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Thalidomide—leprosy	0.00793	0.00793	CcSEcCtD
Quinidine barbiturate—Vertigo—Dapsone—leprosy	0.0079	0.0079	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Thalidomide—leprosy	0.00789	0.00789	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Thalidomide—leprosy	0.00782	0.00782	CcSEcCtD
Quinidine barbiturate—Purpura—Thalidomide—leprosy	0.00776	0.00776	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Thalidomide—leprosy	0.00766	0.00766	CcSEcCtD
Quinidine barbiturate—Lethargy—Thalidomide—leprosy	0.00763	0.00763	CcSEcCtD
Quinidine barbiturate—Diplopia—Thalidomide—leprosy	0.00748	0.00748	CcSEcCtD
Quinidine barbiturate—Affect lability—Thalidomide—leprosy	0.00736	0.00736	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Thalidomide—leprosy	0.00711	0.00711	CcSEcCtD
Quinidine barbiturate—Mood swings—Thalidomide—leprosy	0.00708	0.00708	CcSEcCtD
Quinidine barbiturate—Ataxia—Thalidomide—leprosy	0.00703	0.00703	CcSEcCtD
Quinidine barbiturate—Tachycardia—Dapsone—leprosy	0.00701	0.00701	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Thalidomide—leprosy	0.00683	0.00683	CcSEcCtD
Quinidine barbiturate—Breast disorder—Thalidomide—leprosy	0.00676	0.00676	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00673	0.00673	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Thalidomide—leprosy	0.0066	0.0066	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Thalidomide—leprosy	0.00636	0.00636	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Thalidomide—leprosy	0.0063	0.0063	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Thalidomide—leprosy	0.00614	0.00614	CcSEcCtD
Quinidine barbiturate—Neutropenia—Thalidomide—leprosy	0.00604	0.00604	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Thalidomide—leprosy	0.0059	0.0059	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Dapsone—leprosy	0.00587	0.00587	CcSEcCtD
Quinidine barbiturate—Drowsiness—Thalidomide—leprosy	0.00576	0.00576	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00571	0.00571	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dapsone—leprosy	0.00568	0.00568	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dapsone—leprosy	0.00568	0.00568	CcSEcCtD
Quinidine barbiturate—Renal failure—Thalidomide—leprosy	0.00566	0.00566	CcSEcCtD
Quinidine barbiturate—Sweating—Thalidomide—leprosy	0.00552	0.00552	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Thalidomide—leprosy	0.00538	0.00538	CcSEcCtD
Quinidine barbiturate—Bradycardia—Thalidomide—leprosy	0.00527	0.00527	CcSEcCtD
Quinidine barbiturate—Hepatitis—Thalidomide—leprosy	0.00517	0.00517	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Thalidomide—leprosy	0.00511	0.00511	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Quinidine barbiturate—Visual impairment—Thalidomide—leprosy	0.00499	0.00499	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Thalidomide—leprosy	0.00489	0.00489	CcSEcCtD
Quinidine barbiturate—Eye disorder—Thalidomide—leprosy	0.00483	0.00483	CcSEcCtD
Quinidine barbiturate—Tinnitus—Thalidomide—leprosy	0.00482	0.00482	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Thalidomide—leprosy	0.0048	0.0048	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Thalidomide—leprosy	0.00466	0.00466	CcSEcCtD
Quinidine barbiturate—Chills—Thalidomide—leprosy	0.00464	0.00464	CcSEcCtD
Quinidine barbiturate—Vomiting—Dapsone—leprosy	0.00456	0.00456	CcSEcCtD
Quinidine barbiturate—Mental disorder—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
Quinidine barbiturate—Malnutrition—Thalidomide—leprosy	0.0045	0.0045	CcSEcCtD
Quinidine barbiturate—Headache—Dapsone—leprosy	0.0045	0.0045	CcSEcCtD
Quinidine barbiturate—Tension—Thalidomide—leprosy	0.00442	0.00442	CcSEcCtD
Quinidine barbiturate—Nervousness—Thalidomide—leprosy	0.00437	0.00437	CcSEcCtD
Quinidine barbiturate—Nausea—Dapsone—leprosy	0.00426	0.00426	CcSEcCtD
Quinidine barbiturate—Vision blurred—Thalidomide—leprosy	0.00424	0.00424	CcSEcCtD
Quinidine barbiturate—Tremor—Thalidomide—leprosy	0.00422	0.00422	CcSEcCtD
Quinidine barbiturate—Agitation—Thalidomide—leprosy	0.00414	0.00414	CcSEcCtD
Quinidine barbiturate—Angioedema—Thalidomide—leprosy	0.00411	0.00411	CcSEcCtD
Quinidine barbiturate—Vertigo—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Quinidine barbiturate—Syncope—Thalidomide—leprosy	0.00404	0.00404	CcSEcCtD
Quinidine barbiturate—Leukopenia—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Quinidine barbiturate—Palpitations—Thalidomide—leprosy	0.00398	0.00398	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Thalidomide—leprosy	0.00396	0.00396	CcSEcCtD
Quinidine barbiturate—Convulsion—Thalidomide—leprosy	0.0039	0.0039	CcSEcCtD
Quinidine barbiturate—Arthralgia—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Quinidine barbiturate—Chest pain—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Quinidine barbiturate—Myalgia—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Quinidine barbiturate—Anxiety—Thalidomide—leprosy	0.00382	0.00382	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00381	0.00381	CcSEcCtD
Quinidine barbiturate—Confusional state—Thalidomide—leprosy	0.00371	0.00371	CcSEcCtD
Quinidine barbiturate—Oedema—Thalidomide—leprosy	0.00368	0.00368	CcSEcCtD
Quinidine barbiturate—Shock—Thalidomide—leprosy	0.00362	0.00362	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Quinidine barbiturate—Tachycardia—Thalidomide—leprosy	0.00359	0.00359	CcSEcCtD
Quinidine barbiturate—Skin disorder—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Quinidine barbiturate—Anorexia—Thalidomide—leprosy	0.0035	0.0035	CcSEcCtD
Quinidine barbiturate—Hypotension—Thalidomide—leprosy	0.00343	0.00343	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Thalidomide—leprosy	0.00335	0.00335	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Thalidomide—leprosy	0.00328	0.00328	CcSEcCtD
Quinidine barbiturate—Somnolence—Thalidomide—leprosy	0.00327	0.00327	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Thalidomide—leprosy	0.00319	0.00319	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Quinidine barbiturate—Pain—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Quinidine barbiturate—Constipation—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Thalidomide—leprosy	0.00303	0.00303	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Thalidomide—leprosy	0.00301	0.00301	CcSEcCtD
Quinidine barbiturate—Urticaria—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Thalidomide—leprosy	0.00271	0.00271	CcSEcCtD
Quinidine barbiturate—Asthenia—Thalidomide—leprosy	0.00264	0.00264	CcSEcCtD
Quinidine barbiturate—Pruritus—Thalidomide—leprosy	0.0026	0.0026	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Thalidomide—leprosy	0.00251	0.00251	CcSEcCtD
Quinidine barbiturate—Dizziness—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Quinidine barbiturate—Vomiting—Thalidomide—leprosy	0.00234	0.00234	CcSEcCtD
Quinidine barbiturate—Rash—Thalidomide—leprosy	0.00232	0.00232	CcSEcCtD
Quinidine barbiturate—Dermatitis—Thalidomide—leprosy	0.00232	0.00232	CcSEcCtD
Quinidine barbiturate—Headache—Thalidomide—leprosy	0.0023	0.0023	CcSEcCtD
Quinidine barbiturate—Nausea—Thalidomide—leprosy	0.00218	0.00218	CcSEcCtD
